Isatuximab Approved First-Line for Transplant-Ineligible MM

The CD38 antibody shows improved progression-free survival when added to standard treatment.
Medscape Medical News

source https://www.medscape.com/viewarticle/isatuximab-approved-first-line-transplant-ineligible-mm-2024a1000h7b?src=rss

Comments

Popular posts from this blog

RA and RA-ILD Linked to Higher Lung Cancer Risk

New AAFP practice guideline sets blood pressure targets for adults with hypertension

Heart Failure Care Outside of ICU Can Lower Cost